female swiss mice susceptible to skin tumors received 6 sc injections and/or topical applications of dehydroretronecine , a metabolite of the pyrrolizidine alkaloid monocrotaline , and were observed for 15 months for tumor development .
C0034335
pyrrolizidine
C0085241
monocrotaline